AI Startups Took $61 Billion of North America’s Q3 Funding, Crunchbase Says
The quarterly decline followed unusually large first-half financings. Early- and late-stage deal counts stayed near Q2 levels, complicating the picture of a funding retreat.
Loading page…
The quarterly decline followed unusually large first-half financings. Early- and late-stage deal counts stayed near Q2 levels, complicating the picture of a funding retreat.
Listen to this story
Crunchbase’s Q3 2026 data points to a funding market whose headline contraction was amplified by the lack of new mega-rounds for OpenAI and Anthropic, rather than a broad collapse in deal activity. AI startups still drew $61 billion, while early- and late-stage round counts stayed near Q2 levels even as investment dollars fell. For investors, the signal is concentration: capital remained heavily weighted toward later-stage companies, and the seed tally is provisional because of reporting delays.
Late-stage and technology-growth companies raised $66.45 billion, about a third more than a year earlier.
Early-stage funding totaled $20.6 billion; seed, angel and pre-seed funding was at least $5 billion and may rise as deals are added.
Seventeen venture-backed companies went public in the U.S. and Canada, raising just under $4 billion; no technology debut was a blockbuster.
North American startup funding fell sharply in the third quarter of 2026, but AI companies still captured roughly two-thirds of the money. Crunchbase’s October 7 report puts total investment at $92 billion, down 35% from the previous quarter and up 50% from a year earlier. AI-focused companies received $61 billion.
Crunchbase attributes much of the quarterly drop to the absence of fresh, exceptionally large rounds for OpenAI and Anthropic. Those companies helped push first-half funding to record levels. The report’s author, Joanna Glasner, argues that the lower dollar total does not, by itself, signal a broadly weaker venture investment climate.
Deal counts offer a different view from the headline funding decline: early- and late-stage round counts remained close to the previous quarter’s levels. Investment dollars nevertheless fell across most stages. Early-stage funding retreated from a multiyear peak in Q2, while later-stage funding also declined.
AI funding declined sharply from the first two quarters but remained among the highest quarterly totals on record, according to Crunchbase.
Later-stage companies absorbed most of the capital. More than a dozen startups raised late-stage or growth rounds of at least $1 billion during Q3. The stage breakdown also shows how much less money went to companies at the beginning of their financing journey.
The report also found a subdued quarter for initial public offerings, or IPOs, when companies first sell shares on public exchanges. Seventeen venture-backed North American companies went public on major U.S. and Canadian exchanges, collectively raising just under $4 billion. There were no blockbuster technology debuts; three biotechnology companies raised the largest sums.
The funding figures cover U.S. and Canadian startups from seed through growth stages, rather than global investment. Crunchbase’s methodology uses reported transactions and a data cutoff of October 2, 2026. All amounts are in U.S. dollars. The biggest reporting delays occur at the earliest funding stages, where deals can be added weeks or months after closing.
Loading discussion...
Join the conversation
Explain which measure gives you more confidence, and why.
Be the first to share a perspective or an experience.
Reader comments
Newest comments first. Replies stay oldest first.